FDA Seeks to Pull Nearly 250 ANDAs Over Unsubmitted Annual Reports

FDA Seeks to Pull Nearly 250 ANDAs Over Unsubmitted Annual Reports

Submitted by admin on January 8, 2020 - 11:38pm
Source: 
RAPS.org
News Tags: 
FDA
ANDAs
generics
Headline: 
FDA Seeks to Pull Nearly 250 ANDAs Over Unsubmitted Annual Reports
snippet: 

The US Food and Drug Administration (FDA) on Wednesday said it plans to withdraw the approval of 249 abbreviated new drug applications (ANDAs) after their manufacturers repeatedly failed to submit annual reports for the generic drugs.

Do Not Allow Advertisers to Use My Personal information